Chronic rhinosinusitis-associated olfactory loss

慢性鼻窦炎相关嗅觉丧失

基本信息

  • 批准号:
    7370218
  • 负责人:
  • 金额:
    $ 32.8万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-02-01 至 2011-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The loss of the sense of smell is a common symptom of chronic rhinosinusitis (CRS) that markedly diminishes the quality of life of affected patients. Traditionally, olfactory loss has been thought to occur by obstruction of the olfactory cleft or damage to the olfactory neuroepithelium subsequent to inflammation. While this is true in some cases, it is likely that there are other cellular and molecular mechanisms that modulate olfactory function in CRS. A hallmark feature of CRS is the presence of inflammatory cytokine mediators produced by infiltrating leukocytes. Among these cytokines, tumor necrosis factor alpha (TNF-1) is particularly interesting because of its central role in CRS- associated inflammation and its recognized functions in regulating neurogenesis and patterned neuronal cell death. The PI has recently generated a mouse model of inducible TNF-1 expression specifically within the olfactory epithelium. TNF-1 induction in this model causes loss of odorant sensitivity and, under certain conditions, death of olfactory sensory neurons (OSNs). In many cell types, TNF-1 and other cytokines relevant in CRS directly alter calcium homeostasis through multiple signaling pathways including activation of MAP kinases and the transcription factor NF-:B. It is our hypothesis that inflammatory mediators present in CRS cause olfactory dysfunction through their direct effects on OSNs and olfactory progenitor cells. Our induced olfactory inflammation mouse model provides a novel tool with which to study the effect of acute and chronic inflammation on the function and structure of the olfactory epithelium. The central hypothesis of this proposal is that inflammation induced by TNF-1 promotes the loss of olfaction through three principal mechanisms: 1) desensitization of OSNs to odorants; 2) induction of OSN apoptosis; and 3) inhibition of olfactory epithelial regeneration. An integrated approach involving physiological and molecular techniques will be utilized to dissect the underlying mechanisms of olfactory loss in chronic olfactory inflammation. The experiments described in this proposal will afford new insights into the signaling pathways that mediate inflammatory cytokine effects on neural function and potentially lead to new therapeutic approaches in treating CRS-associated olfactory loss.
描述(由申请人提供):嗅觉丧失是慢性鼻窦炎(CRS)的常见症状,显著降低患者的生活质量。传统上,嗅觉丧失被认为是由嗅觉间隙阻塞或炎症引起的嗅觉神经上皮损伤引起的。虽然这在某些情况下是正确的,但很可能还有其他细胞和分子机制调节CRS的嗅觉功能。CRS的一个标志性特征是浸润白细胞产生的炎症细胞因子介质的存在。在这些细胞因子中,肿瘤坏死因子α (TNF-1)特别有趣,因为它在CRS相关炎症中起核心作用,并在调节神经发生和模式神经元细胞死亡方面具有公认的功能。PI最近建立了一个嗅上皮内特异性诱导TNF-1表达的小鼠模型。在该模型中,TNF-1诱导导致嗅觉敏感性丧失,并在某些条件下导致嗅觉感觉神经元(OSNs)死亡。在许多细胞类型中,TNF-1和其他与CRS相关的细胞因子通过激活MAP激酶和转录因子NF-:B等多种信号通路直接改变钙稳态。我们的假设是,CRS中存在的炎症介质通过直接作用于osn和嗅觉祖细胞而导致嗅觉功能障碍。我们建立的小鼠诱导嗅觉炎症模型为研究急性和慢性炎症对嗅觉上皮功能和结构的影响提供了一种新的工具。该建议的中心假设是,由TNF-1诱导的炎症通过三个主要机制促进嗅觉丧失:1)osn对气味剂的脱敏;2)诱导OSN细胞凋亡;3)嗅觉上皮再生抑制。综合的方法包括生理和分子技术将被用来剖析慢性嗅觉炎症嗅觉丧失的潜在机制。本文所述的实验将为介导炎症细胞因子对神经功能影响的信号通路提供新的见解,并可能为治疗crs相关嗅觉丧失提供新的治疗方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ANDREW P LANE其他文献

ANDREW P LANE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ANDREW P LANE', 18)}}的其他基金

Olfactory mucosa repair and defense: neuro-immune mechanisms and therapy
嗅粘膜修复和防御:神经免疫机制和治疗
  • 批准号:
    10576543
  • 财政年份:
    2023
  • 资助金额:
    $ 32.8万
  • 项目类别:
Innate Immune Regulation of the Epithelium in Chronic Rhinosinusitis with Nasal Polyps
慢性鼻窦炎伴鼻息肉上皮的先天免疫调节
  • 批准号:
    10187233
  • 财政年份:
    2020
  • 资助金额:
    $ 32.8万
  • 项目类别:
Innate Immune Regulation of the Epithelium in Chronic Rhinosinusitis with Nasal Polyps
慢性鼻窦炎伴鼻息肉上皮的先天免疫调节
  • 批准号:
    10343709
  • 财政年份:
    2018
  • 资助金额:
    $ 32.8万
  • 项目类别:
Inflammation-Associated Olfactory Dysfunction: Mechanisms and Therapy
炎症相关的嗅觉功能障碍:机制和治疗
  • 批准号:
    10063819
  • 财政年份:
    2017
  • 资助金额:
    $ 32.8万
  • 项目类别:
Inflammation-Associated Olfactory Dysfunction: Mechanisms and Therapy
炎症相关的嗅觉功能障碍:机制和治疗
  • 批准号:
    10308066
  • 财政年份:
    2017
  • 资助金额:
    $ 32.8万
  • 项目类别:
The Role of ARNO-Arf6 signaling in barrier stability and chronic rhinosinusitis
ARNO-Arf6 信号在屏障稳定性和慢性鼻窦炎中的作用
  • 批准号:
    9060254
  • 财政年份:
    2015
  • 资助金额:
    $ 32.8万
  • 项目类别:
Chronic rhinosinusitis-associated olfactory loss
慢性鼻窦炎相关嗅觉丧失
  • 批准号:
    7859445
  • 财政年份:
    2009
  • 资助金额:
    $ 32.8万
  • 项目类别:
Immune Responses of the Epithelium in Chronic Rhinosinusitis with Polyps
慢性鼻窦炎伴息肉上皮的免疫反应
  • 批准号:
    7925224
  • 财政年份:
    2009
  • 资助金额:
    $ 32.8万
  • 项目类别:
Chronic rhinosinusitis-associated olfactory loss
慢性鼻窦炎相关嗅觉丧失
  • 批准号:
    8473065
  • 财政年份:
    2008
  • 资助金额:
    $ 32.8万
  • 项目类别:
Chronic rhinosinusitis-associated olfactory loss
慢性鼻窦炎相关嗅觉丧失
  • 批准号:
    8668922
  • 财政年份:
    2008
  • 资助金额:
    $ 32.8万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.8万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 32.8万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.8万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.8万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.8万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.8万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.8万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 32.8万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 32.8万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 32.8万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了